Flecaine: Choice treatment for supraventricular tachycardia with hydrops fetalis;La Flecaine®: Un traitement de choix dans les tachycardies supra-ventriculaires avec anasarque. A propos d'un cas

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 26, Issue 1, 1997, Pages 37-39

  Hamel, Ph ^a   Febbraro, W ^a   Barjot, Ph ^a   Lindet, Y ^a   Muller, G ^a   Iselin, M ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Cardiologue   (France)

Author keywords

flecainide acetate; supraventricular tachycardia

Indexed keywords

FLECAINIDE ACETATE; ANTIARRHYTHMIC AGENT; FLECAINIDE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FETUS; FETUS HYDROPS; HEART FAILURE; HUMAN; ORAL DRUG ADMINISTRATION; SUPRAVENTRICULAR TACHYCARDIA; CONGESTIVE HEART FAILURE; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FETUS DISEASE; PREGNANCY;

ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY; FEMALE; FETAL DISEASES; FLECAINIDE; HEART FAILURE, CONGESTIVE; HUMANS; HYDROPS FETALIS; PREGNANCY; TACHYCARDIA, SUPRAVENTRICULAR; ULTRASONOGRAPHY, PRENATAL;

EID: 0030615165     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;66:46-8.
2. Van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-5.
3. Maxwell DJ, Crawford DC, Curry PVM, Tynan MJ, Allan LD. Obstetric importance, diagnosis, and management of fetal tachycardias. Br Med J 1988;297:107-10.
4. Wren C. Hunter S. Maternal administration of flecainide to terminate and suppress fetal tachycardia. Br Med J 1988;296:249.
5. Kofinas AD, Simon NV, Sagel H, Lyttle E, Smith N, King K. Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxine failure. Am J Obstet Gynecol 1991;165:630-1.
6. Maragnes P, Foumier A, Lessard M, Fouron JC. Evaluation et pronostic des arythmies fœtales. Pediatrie 1991;46:481-8.
7. Weiner CP, Thompson MIB. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am. J Obstet Gynecol 1988;158: 570-3.
8. Perry JC, McQuinn RL, Smith RT, Gothing C, Fredell P, Garson A. Flecainide acetate for resistant arythmias in the young. J Am Coll Cardiol 1989;14:185-91.
9. Wren C, Campbell RWF. The response of paediatric arythmias to intravenous and oral flecainide. Br Heart J 1987;57:171-5.
10. Perry JC, Ayres NA, Carpenter RJ. Fetal supraventricular tachycardia treated with flecainide acetate. J Pediatr 1991;118:303-05.
11. Mills M. Treatment of fetal supraventricular tachycardia with flecainide acetate after digoxine failure. Am J Obstet Gynecol 1992;166:1863.
12. The Cardiac Arythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomised trial of arythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
13. McQuinn RL, Pisani A, Wafa S, Chang SF, Miller AM, Frappell JM, et al. Flecainide excretion in human breast milk. Clin Pharmacol Ther 1990;48:262-7.
14. Van Gelder Hasker MR, De Jong CLD, Devries JIP, Van Geijn HP. The effect of flecainide acetate on fetal heart rate variability: A case report. Obstet Gynecol 1995;86:667-9.